Pharmaceutical Waste Management: A Comprehensive Analysis of Romanian Practices and Perspectives
Abstract
:1. Introduction
2. Materials and Methods
2.1. Research Objectives
2.2. Research Design and Data Collection
- Removing medication from the original package;
- Using a unit-dose distributing system;
- Adapting or renewing the prescribed quantity of medications by pharmacists;
- Managing medication quantities held in stock-by-stock rotation;
- Verifying medication quantities held in stock by checking expiry dates;
- Controlling medications that are unused;
- Removing medications that are expired;
- Cooperating with other organizations to trade almost expired medications;
- Dispatching unopened medications that can be ‘reutilized’ back to the manufacturer;
- Notifying prescribers/managers about the unused medications in order not to be commanded;
- Offering patients information on how to manage expired or unwanted medications;
- Permitting patients to give back their leftover medicines to the pharmacy;
- Advising the patients on the quantity needed for symptom recovery;
- Collecting unutilized medications so they can be recycled;
- Donating unused medications;
- Understanding the legislation concerning waste disposal;
- Poor education regarding waste management;
- Insufficient dustbins; inadequate recycling facilities;
- Insufficient landfill disposal places;
- Attitude of the pharmacists’ communities.
2.3. Data Processing
- Removing medication from the original package;
- Managing the medication quantities held in stock-by-stock rotation;
- Verifying the medication quantities held in stock by checking expiry dates;
- Controlling the medications that are unused or expired;
- Dispatching unopened medications that are ‘reusable’ back to the manufacturer;
- Offering patients information on how to manage expired or unwanted medications;
- Permitting patients to give back their leftover medicines to the pharmacy;
- Advising the patients on the quantity needed for symptom recovery;
- Collecting unutilized medications so they can be recycled;
- Understanding the legislation concerning waste disposal;
- Inadequate recycling facilities.
- Insufficient control for implementing legal content by the responsible specialists;
- Ineffective control over pharma recycling costs and inappropriate budgeting;
- Limited knowledge about pharma waste management;
- An inadequate framework for facilitating stakeholder dialogue;
- The general assumption that the government is the exclusively responsible for pharmacies’ waste management;
- Declining volunteerism and increasing personal profit-seeking behaviors address underlying economic, social, and cultural factors;
- A lack of national expired or unused medicines storage programs to create and strengthen connections with the community;
- Limited political commitment;
- Insufficient educational programs regarding recycling/reusing pharma products;
- Weak involvement of the citizens, health care professionals, and specialized organizations;
- An absence of different activities to plan, monitor, and assess performance;
- Limited information regarding the technical capabilities and objectives of the specialized institutions;
- An absence of standardization in packaging and materials creates challenges in developing recycling processes that can be applied universally;
- Reduced recycling feasibility due to the multi-material packaging of pharmaceutical products;
- Limited specialized facilities and equipment to manage the unique challenges associated with pharmaceutical waste;
- The implementation of advanced recycling technologies and offering compliance with international regulations involve high costs;
- Establishing efficient reverse-logistics systems to collect and transport pharmaceutical waste back to recycling facilities can be a logistical challenge, especially when dealing with diverse and widespread sources;
- Pharmaceutical products are not designed for recyclability at the development stage;
- Coordinating recycling across different regions and ensuring consistency can be complex due to the international supply chains with multiple stakeholders;
- Consumer habits regarding pharma product recycling.
3. Results
3.1. Demographic Characteristics
3.2. Pharmacies’ Activities to Reduce Waste
3.3. Delphi Technique Results
4. Discussion
4.1. Research Findings
4.2. Implications and Suggestions
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Grand View Research. Medical Waste Management Market Size, Share & Trends Analysis Report by Treatment Site (Onsite, Offsite), by Treatment (Incineration, Autoclaving, Chemical Treatment), by Region, and Segment Forecasts, 2024–2030. Available online: https://www.grandviewresearch.com/industry-analysis/medical-waste-management-market (accessed on 6 October 2023).
- Statista. Pharmaceutical Industry in Romania—Statistics & Facts. Available online: https://www.statista.com/topics/8634/pharmaceutical-industry-in-romania/#topicOverview (accessed on 6 October 2023).
- Alemu, A.B.; Ibrahim, N.A.; Argaw, K.W. Magnitude of medicine wastage and perceived contributing factors among public health facilities in Dire-Dawa City administration, in mid COVID-19 pandemic in Ethiopia: Retrospective, Cross-Sectional Study. Integr. Pharm. Res. Pract. 2023, 12, 61–75. [Google Scholar] [CrossRef] [PubMed]
- Ayele, Y.; Mamu, M. Assessment of knowledge, attitude, and practice towards disposal of unused and expired pharmaceuticals among community in Harar city, Eastern Ethiopia. J. Pharm. Policy Pract. 2018, 11, 27. [Google Scholar] [CrossRef]
- Kahssay, S.W.; Hammeso, W.W.; Getachew, D.; Woldeselassie, B.D. Prevalence, and determinants of household medication storage during the COVID-19 outbreak in Southwest Ethiopia. Drug Healthc. Patient Saf. 2023, 15, 1–11. [Google Scholar] [CrossRef] [PubMed]
- Gwenzi, W.; Simbanegavi, T.T.; Rzymski, P. Household disposal of pharmaceuticals in Low-Income settings: Practices, health hazards, and research needs. Water 2023, 15, 476. [Google Scholar] [CrossRef]
- Coman, E.; Coman, C.; Repanovici, A.; Baritz, M.; Kovacs, A.; Tomozeiu, A.M.; Barbu, S.; Toderici, O. Does Sustainable Consumption Matter? The Influence of the COVID-19 Pandemic on Medication Use in Brasov, Romania. Sustainability 2022, 14, 8017. [Google Scholar] [CrossRef]
- Banjar, H.; Alrowithi, R.; Alhadrami, S.; Magrabi, E.; Munshi, R.; Alrige, M. An Intelligent System for Proper Management and Disposal of Unused and Expired Medications. Int. J. Environ. Res. Public Health. 2022, 19, 2875. [Google Scholar] [CrossRef]
- World Health Organization. Promoting Rational Use of Medicines. Available online: https://www.who.int/activities/promoting-rational-use-of-medicines (accessed on 29 November 2023).
- Mohammed, S.A.; Kahissay, M.H.; Hailu, A.D. Pharmaceuticals wastage and pharmaceuticals waste management in public health facilities of Dessie town, North East Ethiopia. PLoS ONE 2021, 16, e0259160. [Google Scholar] [CrossRef] [PubMed]
- Alhomoud, F. “Don’t Let Medicines Go to Waste”—A SurveyBased Cross-Sectional Study of Pharmacists’ Waste-Reducing Activities Across Gulf Cooperation Council Countries. Front. Pharmacol. 2020, 11, 1334. [Google Scholar] [CrossRef] [PubMed]
- West, L.; Diack, L.; Cordina, M.; Stewart, D. Applying the Delphi technique to define “medication wastage”. Eur. J. Hosp. Pharm. 2015, 22, 274–279. [Google Scholar] [CrossRef]
- Rogowska, J.; Zimmermann, A. Household pharmaceutical waste disposal as a global problem—A Review. Int. J. Environ. Res. Public Health 2022, 19, 15798. [Google Scholar] [CrossRef]
- Insani, W.N.; Qonita, N.A.; Jannah, S.S.; Nuraliyah, N.M.; Supadmi, W.; Gatera, V.A.; Alfian, S.D.; Abdulah, R. Improper disposal practice of unused and expired pharmaceutical products in Indonesian households. Heliyon 2020, 6, e04551. [Google Scholar] [CrossRef]
- Makki, M.; Hassali, M.A.; Awaisu, A.; Hashmi, F. The prevalence of unused medications in homes. Pharmacy 2019, 7, 61. [Google Scholar] [CrossRef]
- Law, A.V.; Sakharkar, P.; Zargarzadeh, A.; Tai, B.W.B.; Hess, K.; Hata, M.; Mireles, R.; Ha, C.; Park, T.J. Taking stock of medication wastage: Unused medications in US households. Res. Soc. Adm. Pharm. 2015, 11, 571–578. [Google Scholar] [CrossRef] [PubMed]
- Singleton, J.A.; Lau, E.T.-L.; Nissen, L.M. Pharmaceutical waste disposal practices: A case study of an Australian public hospital pharmacy department. J. Pharm. Pract. Res. 2023, 53, 56–63. [Google Scholar] [CrossRef]
- West, L.M. Medication wastage: The current situation. J. Malta Coll. Pharm. Pract. 2015, 21, 25–28. [Google Scholar]
- Janik-Karpinska, E.; Brancaleoni, R.; Niemcewicz, M.; Wojtas, W.; Foco, M.; Podogrocki, M.; Bijak, M. Healthcare Waste—A Serious Problem for Global Health. Healthcare 2023, 11, 242. [Google Scholar] [CrossRef] [PubMed]
- Kadam, A.; Patil, S.; Patil, S.; Tumkur, A. Pharmaceutical Waste Management and Overview. Indian J. Pharm. Pract. 2016, 9, 2–8. [Google Scholar] [CrossRef]
- Bekker, C.L.; Van Den Bemt, B.J.F.; Egberts, A.C.G.; Bouvy, M.L.; Gardarsdottir, H. Patient and medication factors associated with preventable medication waste and possibilities for redispersing. Int. J. Clin. Pharm. 2018, 40, 704–711. [Google Scholar] [CrossRef]
- Javorac, D.; Maric, D.; Baralic, K.; Miljaković, E.A.; Djordjević, A.B.; Djukić-Ćosić, D.; Ćurčić, M.; Antonijević, B.; Bulat, Z. The role of pharmacist in reducing the impact of air pollution on human health. Arch. Pharm. 2022, 72, 613–614. [Google Scholar]
- Jonjić, D.; Vitale, K. Issues around household pharmaceutical waste disposal through community pharmacies in Croatia. Int. J. Clin. Pharm. 2014, 36, 556–563. [Google Scholar] [CrossRef]
- Kusturica, M.P.; Sabo, A.; Tomic, Z.; Horvat, O.; Šolak, Z. Storage and disposal of unused medications: Knowledge, behavior, and attitudes among Serbian people. Int. J. Clin. Pharm. 2012, 34, 604–610. [Google Scholar] [CrossRef] [PubMed]
- Thane, G. A Call to Action: An Evidence Review on Pharmaceutical Disposal in the Context of Antimicrobial Resistance in Canada, NCCID. 2021. Available online: https://nccid.ca/wp-content/uploads/sites/2/2021/03/A-Call-to-Action-An-Evidence-Review-on-Pharmaceutical-Disposal-in-the-Context-of-Antimicrobial-Resistance-in-Canada.pdf (accessed on 4 May 2024).
- Chameleon Pharma. Romania’s OTC & Pharma Market Opportunities. Available online: https://www.chameleon-pharma.com/romanias-otc-pharma-market-opportunities (accessed on 29 October 2023).
- Ministry of Health’s Order 444/2019. Available online: https://www.anm.ro/_/ORDINE/OMS%20444%20din%202019.pdf (accessed on 5 May 2024).
- Akurugu, E.; Issahaku, A.M.; Aliou, A.S. Application of Factor Analysis in the Assessment of Solid Waste Management in Bolgatanga Municipality of Ghana. Sci. J. Appl. Math. Stat. 2018, 6, 99–109. [Google Scholar] [CrossRef]
- Mouloudj, K.; Njoku, A.; Asanza, D.M.; Bouarar, A.C.; Evans, M.A.; Mouloudj, S.; Bouarar, A. Modeling Predictors of Medication Waste Reduction Intention in Algeria: Extending the Theory of Planned Behavior. Int. J. Environ. Res. Public Health 2023, 20, 6584. [Google Scholar] [CrossRef] [PubMed]
- Alshemari, A.; Breen, L.; Quinn, G.; Sivarajah, U. Can We Create a Circular Pharmaceutical Supply Chain (CPSC) to Reduce Medicines Waste? Pharmacy 2020, 8, 221. [Google Scholar] [CrossRef] [PubMed]
- Shukla, S.; Halli, P.; Khalid, M.K.; Lundström, M. Waste Pharmaceutical Blister Packages as a Source of Secondary Aluminum. JOM 2022, 74, 612–662. [Google Scholar] [CrossRef]
- Bungau, S.; Tit, D.M.; Fodor, K.; Cioca, G.; Agop, M.; Iovan, C.; Cseppento, D.C.N.; Bumbu, A.; Bustea, C. Aspects Regarding the Pharmaceutical Waste Management in Romania. Sustainability 2018, 10, 2788. [Google Scholar] [CrossRef]
- Castensson, S. Pharmaceutical Waste. In Pharmaceuticals in the Environment; Kümmerer, K., Ed.; Springer: Berlin/Heidelberg, Germany, 2008. [Google Scholar] [CrossRef]
- Aryal, M.; Adhikary, S. Solid waste management practices and challenges in Besisahar municipality, Nepal. PLoS ONE 2024, 19, e0292758. [Google Scholar] [CrossRef] [PubMed]
- Riikonen, S.; Timonen, J.; Sikanen, T. Environmental considerations along the life cycle of pharmaceuticals: Interview study on views regarding environmental challenges, concerns, strategies, and prospects within the pharmaceutical industry. Eur. J. Pharm. Sci. 2024, 196, 106743. [Google Scholar] [CrossRef] [PubMed]
- Karkori, F. Waste Management and Disposal. In Ship Sanitation, Health and Hygiene; Synthesis Lectures on Ocean Systems Engineering; Springer: Berlin/Heidelberg, Germany, 2024. [Google Scholar] [CrossRef]
- Dixit, A.; Dutta, P. Critical success factors for the adoption of circular economy in sustainable healthcare waste management. Clean Technol. Environ. Policy 2024, 26, 2181–2201. [Google Scholar] [CrossRef]
- Ashiwaju, B.I.; Uzougbo, C.G.; Orikpete, O.F. Environmental Impact of Pharmaceuticals: A Comprehensive Review. Matrix Sci. Pharma 2023, 7, 85–94. [Google Scholar] [CrossRef]
- Sathish Kumar, V.; Dhivakar, M.; Nagamani, S.; Dhanalakshmi, A.; Leema Margret, A. Removal of pharmaceuticals from wastewater: A review of different adsorptive approaches. Glob. NEST J. 2024, 26, 1–11. [Google Scholar] [CrossRef]
- Martin-Rios, C.; Meier, C.; Pasamar, S. Sustainable waste management solutions for the foodservice industry: A Delphi study. Waste Manag. Res. 2022, 40, 1412–1423. [Google Scholar] [CrossRef] [PubMed]
- Mukherjee, N.; Sutherland, W.J.; Khan, M.N.I.; Berger, U.; Schmitz, N.; Dahdouh-Guebas, F.; Koedam, N. Using expert knowledge and modeling to define mangrove composition, functioning, and threats and estimate time frame for recovery. Ecol. Evol. 2014, 4, 2247–2262. [Google Scholar] [CrossRef] [PubMed]
- Okoli, C.; Pawlowski, S.D. The Delphi method as a research tool: An example, design considerations and applications. Inf. Manag. 2004, 42, 15–29. [Google Scholar] [CrossRef]
- Donohoe, H.M.; Needham, R.D. Moving best practice forward: Delphi characteristics, advantages, potential problems, and solutions. Int. J. Tour. Res. 2009, 11, 415–437. [Google Scholar] [CrossRef]
- Hastie, T.J.; Tibshirani, R.; Friedman, J.H. The Elements of Statistical Learning: Data Mining, Inference, and Prediction, 2nd ed.; Springer Series in Statistics: Berlin/Heidelberg, Germany, 2009. [Google Scholar]
- Hair, J.F.; Anderson, R.E.; Tatham, R.L.; Black, W.C. Multivariate Data Analysis with Readings; Prentice-Hall: Upper Saddle River, NJ, USA, 2010. [Google Scholar]
- Sawyer, S.F. Analysis of Variance: The Fundamental Concepts. J. Man. Manip. Ther. 2009, 17, 27E–38E. [Google Scholar] [CrossRef]
- Kadaifci, C.; Karadayi-Usta, S.; Yanmaz, O. An analysis of consumer opinions on waste medicine management utilizing fermatean fuzzy cognitive mapping. Environ. Dev. 2024, 49, 10096. [Google Scholar] [CrossRef]
- Raj, A.; Samuel, C.; Singh, A.K. Addressing the healthcare waste management barriers: A structural equation modeling approach. Health Serv. Manag. Res. 2023, 3, 9514848231186775. [Google Scholar] [CrossRef]
- Sapkota, B.; Pariatamby, A. Pharmaceutical waste management system—Are the current techniques sustainable, eco-friendly, and circular? Rev. Waste Manag. 2023, 168, 83–97. [Google Scholar] [CrossRef]
- Al-Awamleh, H.; Alhalalmeh, M.; Alatyat, Z.; Saraireh, S.; Akour, I.; Alneimat, S.; Al-Hawary, S. The effect of green supply chain on sustainability: Evidence from the pharmaceutical industry. Uncertain Supply Chain Manag. 2022, 10, 1261–1270. [Google Scholar] [CrossRef]
- Aityassine, F.; Aldiabat, B.; Al-rjoub, S.; Aldaihani, F.; Al-Shorman, H.; Al-Hawary, S. The mediating effect of just in time on the relationship between green supply chain management practices and performance in manufacturing companies. Uncertain Supply Chain Manag. 2021, 9, 1081–1090. [Google Scholar]
- Amitha, A.J.; Manoj, V. Sustainable Waste Management: Policies and Case Studies; Ghosh, S.K., Ed.; 7th IconSWM—ISWMAW; Springer: Berlin/Heidelberg, Germany, 2017; Volume 1, pp. 167–181. [Google Scholar]
- Das, A.K.; Islam, N.; Billah, M.; Sarker, A. COVID-19 pandemic, and healthcare solid waste management strategy—A mini-review. Sci. Total Environ. 2021, 778, 146220. [Google Scholar] [CrossRef] [PubMed]
- Smale, E.; Toine Egberts, C.G.; Heerdink, E.R.; Van den Bemt, B.; Bekker, C.L. Waste-minimizing measures to achieve sustainable supply and use of medication. Sustain. Chemist. Pharm. 2021, 20, 100400. [Google Scholar] [CrossRef]
- Babaee Tirkolaee, E.; Aydın, S.N. A sustainable medical waste collection and transportation model for pandemics. Waste Manag. Res. 2021, 39 (Suppl. S1), 34–44. [Google Scholar] [CrossRef] [PubMed]
- Bakiu, R.; Durmishaj, S. Medical waste effects and management: Overview and future directions. SF J. Environ. Earth Sci. 2018, 1, 1019. [Google Scholar]
- Jebb, A.; Ng, V.; Tay, L. A Review of Key Likert Scale Development Advances: 1995–2019. Front. Psychol. Sec. Quant. Psychol. Meas. 2021, 12, 637547. [Google Scholar] [CrossRef] [PubMed]
- Sullivan, G.M.; Artino, A.R., Jr. Analyzing and interpreting data from Likert-type scales. J. Grad. Med. Ed. 2013, 5, 541–542. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Paterson, J.M.; Anderson, G.M. “Trial” prescriptions to reduce drug wastage: Results from Canadian programs and a community demonstration project. Am. J. Manag. Care 2002, 8, 151–158. [Google Scholar] [PubMed]
- Wajid, S.; Siddiqui, N.A.; Mothana, R.A.; Samreen, S. Prevalence and Practice of Unused and Expired Medicine—A Community Based Study among Saudi Adults in Riyadh, Saudi Arabia. BioMed Res. Int. 2020, 2020, 6539251. [Google Scholar] [CrossRef]
- Abuassonon, A.A.; Kalkatawi, B.S.; Alzahrani, L.S.; Eid, B.G.; Neamatallah, T.A. Practices of Jeddah Residents Regarding the Disposal of Unused and Expired Medications: A Community-Based Survey. JKAU Med. Sci. 2019, 26, 35–44. [Google Scholar] [CrossRef]
- Ivars-Baidal, J.A.; Celdrán-Bernabeu, M.A.; Mazón, J.N.; Perles-Ivars, Á.F. Smart destinations and the evolution of ICTs: A new scenario for destination management? Curr. Issues Tour. 2019, 22, 1581–1600. [Google Scholar] [CrossRef]
- Sagdoldanova, A.; Atymtayeva, L. Expert system for pharmacy. In Proceedings of the 14th International Scientific Conference Information Technology and Management, Riga, Latvia, 14–15 April 2016; pp. 827–832. [Google Scholar]
- Comendador, B.E.V.; Francisco, B.M.B.; Medenilla, J.S.; Mae, S. Pharmabot: A pediatric generic medicine consultant chatbot. J. Autom. Control Eng. 2015, 3, 137–140. [Google Scholar] [CrossRef]
- The Preservation of Grace Association. Ministry of Social Affairs and Labor, No. 1746/4/s. 2005. Available online: http://www.hifz.org/detail.aspx?CID=2&lID=62 (accessed on 14 November 2023).
- Medicine Charity Association. Ministry of Social Affairs in the Kingdom of Saudi Arabia with Permit No. 541. Available online: https://dwaa.org.sa/ (accessed on 13 November 2023).
- Saudi Food & Drug Authority. 2021. Available online: https://www.sfda.gov.sa/ar/authority-establishment (accessed on 23 November 2023).
- Rydzkowski, T.; Wróblewska-Krepsztul, J.B.; Thakur, V.K.; Królikowski, T.P. Current trends of intelligent, smart packagings in new medical applications. Procedia Comput. Sci. 2022, 207, 1271–1282. [Google Scholar] [CrossRef]
- Wangz, B.; Yao, Z.; Reinmöller, M.; Kishore, N.; Tesfaye, F.; Luque, R. Pyrolysis behavior, kinetics, and thermodynamics of waste pharmaceutical blisters under CO2 atmosphere. J. Anal. Appl. Pyrolysis 2023, 70, 105883. [Google Scholar] [CrossRef] [PubMed]
- Nieminen, J.; Anugwom, I.; Kallioinen, M.; Mänttäri, M. Green solvents in recovery of aluminium and plastic from waste pharmaceutical blister packaging. Waste Manag. 2020, 107, 20–27. [Google Scholar] [CrossRef] [PubMed]
- Dalai, S.; Marthati, M.B.; Datla, A.V.; Maturu, M.V.S.; Yellapu, R.N. Multiple Ruptured Aneurysms Over Basilar Artery Fenestration: Endovascular Management. Cureus 2022, 29, e21719. [Google Scholar] [CrossRef] [PubMed]
- Kremser, K.; Schon, H.; Gerl, P.; Valera Gomez, M.A.; Ramirez Espinosa, D.; Morandini, A.; Argilés, M.P.; Martínez, B.M.; Guebitz, G.M. Pharmaceutical blister waste recycling using biogenic sulfuric acid: Effect of sulfur source and blister material on bioleaching efficiency. Hydrometallurgy 2023, 221, 106124. [Google Scholar] [CrossRef]
- Tracy, T.; Wu, L.; Liu, X.; Cheng, S.; Li, X. 3D printing: Innovative solutions for patients and pharmaceutical industry. Int. J. Pharm. 2023, 631, 122480. [Google Scholar] [CrossRef]
- Khan, M.T.; Shah, I.A.; Ihsanullah, I.; Naushad, M.; Ali, S.; Shah, S.H.A.; Mohammad, A.W. Hospital wastewater as a source of environmental contamination: An overview of management practices, environmental risks, and treatment processes. J. Water Process. Eng. 2021, 41, 101990. [Google Scholar] [CrossRef]
Characteristics | Percent from Total Sample |
---|---|
Age | |
Under 24 years | 5.7% |
25–34 years | 39.3% |
35–44 years | 31.1% |
Over 45 years | 23.9% |
Job sector | |
Public (hospital) pharmacy | 21.6% |
Private pharmacy | 78.4% |
Education | |
Pharmacy technician’s Degree | 28.4% |
Bachelor’s Degree | 33.5% |
Master’s Degree | 27.3% |
Ph.D. Degree | 10.8% |
Occupation | |
Hospital pharmacist/technician | 18.7% |
Drugstore pharmacist/technician | 58.2% |
Pharmaceutical company pharmacist/technician | 23.1% |
Years of work experience | |
<5 years | 36.2% |
5–10 years | 38.6% |
>10 years | 25.2% |
Monthly income | |
Under 1000 EUR | 68.08% |
Between 1000–1500 EUR | 21.02% |
Over 1500 EUR | 10.9% |
The type of pharmaceutical waste you mostly try to reduce | |
Hazardous waste | 28.8% |
Non- hazardous waste | 71.2% |
Type | Work Position | Respondent | Work Experience -Years- |
---|---|---|---|
University | University 1 | Professor Ph.D. | 21 |
University 2 | Associate Professor Ph.D. | 15 | |
University 3 | Professor Ph.D. | 28 | |
Pharmacy | Pharmacy 1 | General Manager | 17 |
Pharmacy 2 | Sales Manager | 12 | |
Pharmacy 3 | General Manager | 9 | |
Pharmacy 4 | General Manager | 19 | |
Pharmacy 5 | Sales Manager | 6 | |
Ministry | Representative 1 | Specialist | 23 |
Representative 2 | Manager | 11 | |
Manufactory | Manufactory 1 | Production Manager | 8 |
Manufactory 2 | Logistic Manager | 9 | |
Manufactory 3 | General Manager | 16 | |
Manufactory 4 | General Manager | 10 | |
Manufactory 5 | Production Manager | 5 |
Items | Mean | SD |
---|---|---|
Removing medication from the original package | 4.0907 | 0.73212 |
Using a unit-dose distributing system | 1.9003 | 0.67821 |
Adapting or renewing the prescribed quantity of medications by pharmacists | 2.0420 | 0.78904 |
Managing the medication quantities held in stock-by-stock rotation | 3.1370 | 0.76247 |
Verifying the medication quantities held in stock by checking expiry dates | 4.8602 | 0.90423 |
Controlling medications that are unused | 4.0202 | 0.87653 |
Removing medications that are expired | 4.5612 | 0.90012 |
Cooperating with other organizations to trade almost expired medications | 1.8756 | 0.56792 |
Dispatching unopened medications that can be ‘reutilized’ back to the manufacturer | 2.2452 | 0.45023 |
Notifying prescribers/managers about the unused medications in order not to be commanded | 1.0075 | 0.12095 |
Offering patients information on how to manage the expired or unwanted medications | 3.2023 | 0.98730 |
Permitting patients to give back their leftover medicines to the pharmacy | 2.1280 | 0.89345 |
Advising the patients on the quantity needed for symptom recovery | 3.1063 | 0.78903 |
Collecting unutilized medications so they can be recycled | 1.1301 | 0.89054 |
Donating unused medications | 2.0989 | 0.78903 |
Unclear legislation concerning waste disposal | 3.1234 | 0.69045 |
Poor education regarding waste management | 2.3990 | 0.08563 |
Insufficient dustbins | 4.0074 | 0.87383 |
Insufficient landfill disposal places | 3.4750 | 0.20938 |
Inadequate recycling facilities | 1.7845 | 0.79032 |
Attitude of the pharmacists’ communities | 2.0912 | 0.74656 |
Satisfaction Items | Factor 1 | Factor 2 | Factor 3 |
---|---|---|---|
Removing medication from the original package | 0.828 | ||
Managing the medication quantities held in stock-by-stock rotatio | 0.558 | ||
Verifying the medication quantities held in stock by checking expiry dates | 0.502 | ||
Controlling medications that are unused or expired | 0.898 | ||
Dispatching unopened medications that are ‘reusable’ back to the factory | 0.634 | ||
Offering consumers information on how to manage expired or unwanted medications | 0.890 | ||
Permitting patients to give back their leftover medicines to the pharmacy | 0.887 | ||
Advising the patients on the quantity needed for symptom recovery | 0.609 | ||
Collecting unutilized medications so they can be recycled | 0.621 | ||
Unclear legislation concerning waste disposal | 0.612 | ||
Inadequate recycling facilities | 0.512 | ||
Eigenvalues | 2.89 | 1.85 | 1.32 |
Percent of variance explained | 32.17% | 18.23% | 13.38% |
Satisfaction Factor | |||
---|---|---|---|
Occupation | The Release Stage—Pharmacy-Associated Activities | The Release Stage—Pharmacy Patient-Associated Activities | The Remaining Stage |
Mean | Mean | Mean | |
Hospital pharmacist/technician | 4.59 | 4.01 | 3.08 |
Drugstore pharmacist/technician | 4.83 | 4.41 | 3.14 |
Pharmaceutical company pharmacist/technician | 3.89 | 3.78 | 3.98 |
General mean | 4.44 | 4.07 | 3.4 |
ANOVA F | 11.298 | 5.321 | 0.911 |
Sig. | 0.000 | 0.001 | 0.325 |
Recycling/Reusing Intentions | Hospital Pharmacist/Technician | Drugstore Pharmacist/Technician | Pharmaceutical Company Pharmacist/Technician | Pearson Chi-Square | Sig. |
---|---|---|---|---|---|
Yes | 71.4% | 84.1% | 74.9% | 49.87 | 0.00 |
No | 28.6% | 15.9% | 25.1% |
Range | Level |
---|---|
1.00–1.80 | unimportant |
1.81–2.60 | of little importance |
2.61–3.40 | moderately important |
3.41–4.20 | important |
4.21–5.00 | very important |
Institutional Barrier | Round | Mean |
---|---|---|
Lack of national expired or unused medicine storage programs to create and strengthen connections with the community | First round Second round | 4.88 4.94 |
Limited specialized facilities and equipment to manage the unique challenges associated with pharmaceutical waste | First round Second round | 4.79 4.86 |
Ineffective control over pharmaceutical recycling costs and inappropriate budgeting | First round Second round | 4.72 4.78 |
Insufficient control over implementing legal content for the responsible specialists | First round Second round | 4.67 4.71 |
Limited political commitment | First round Second round | 4.53 4.46 |
Insufficient educational programs regarding recycling/reusing pharmaceutical products | First round Second round | 4.40 4.45 |
Absence of different activities to plan, monitor, and assess performance | First round Second round | 4.32 4.29 |
Limited information regarding the technical capabilities and objectives of specialized institutions | First round Second round | 4.28 4.20 |
Absence of standardization in packaging and materials creates challenges in developing recycling processes that can be applied universally | First round Second round | 4.21 4.29 |
Reduced recycling feasibility due to the multi-material packaging of pharmaceutical products | First round Second round | 4.19 4.20 |
Implementation of advanced recycling technologies and offering compliance with international regulations involve high costs | First round Second round | 3.98 4.17 |
Establishing efficient reverse-logistics systems to collect and transport pharmaceutical waste back to recycling facilities can be a logistical challenge, especially when dealing with diverse and widespread sources | First round Second round | 3.83 3.97 |
Pharmaceutical products are not designed for recyclability at the development stage | First round Second round | 3.76 3.71 |
Coordinating recycling across different regions and ensuring consistency can be complex due to the international supply chains with multiple stakeholders | First round Second round | 3.63 3.57 |
Behavioral Barrier | Round | Mean |
---|---|---|
Consumer habits regarding pharma product recycling | First round Second round | 4.53 4.64 |
An inadequate framework for facilitating stakeholder dialogue | First round Second round | 4.48 4.59 |
Limited knowledge about pharmaceutical waste management | First round Second round | 4.33 4.39 |
Declining volunteerism and increasing personal profit-seeking behaviors | First round Second round | 4.26 4.21 |
The general assumption that the government is exclusively responsible for pharmacy waste management | First round Second round | 3.33 3.21 |
The general weak involvement of the citizens, health care professionals, and specialized organizations | First round Second round | 3.25 3.16 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Ionescu, A.-M.; Cazan, C. Pharmaceutical Waste Management: A Comprehensive Analysis of Romanian Practices and Perspectives. Sustainability 2024, 16, 6571. https://doi.org/10.3390/su16156571
Ionescu A-M, Cazan C. Pharmaceutical Waste Management: A Comprehensive Analysis of Romanian Practices and Perspectives. Sustainability. 2024; 16(15):6571. https://doi.org/10.3390/su16156571
Chicago/Turabian StyleIonescu, Ana-Maria, and Cristina Cazan. 2024. "Pharmaceutical Waste Management: A Comprehensive Analysis of Romanian Practices and Perspectives" Sustainability 16, no. 15: 6571. https://doi.org/10.3390/su16156571
APA StyleIonescu, A.-M., & Cazan, C. (2024). Pharmaceutical Waste Management: A Comprehensive Analysis of Romanian Practices and Perspectives. Sustainability, 16(15), 6571. https://doi.org/10.3390/su16156571